Therefore, more work needs to be done to establish which TGFβ ligand is playing a role in tumor progression, whether there are differences between tumor and stromal cell types, and the implications of each TGFβ ligand for ovarian cancer progression. This evidence concerns the gene TGFB1 and ovarian cancer.